In an interview to CNBC-TV18, Satyanarayana Chava, Founder & CEO, Laurus Labs spoke about the results and latest happenings in the company.
The company has received final approval for its Quetiapine Fumarate extended-release tablets in different strengths from the United States Food and Drug Administration (FDA), Lupin Ltd said in a statement.
A look at the performance of sectors during the current fiscal and how they would perform going forward.
The US drug regulator off late, has been a cause of headaches for many domestic pharmaceutical companies. Today, shares of Divis Laboratories tanked 20 percent after an import alert was issued its on Vizag unit. The Dr Reddy's Laboratories shares also hit a 52-week low after the company's Duvvada plant received 13 observations which included repeats from a November, 2015 warning letter.
The drug firm received establishment inspection report (EIR) from the US Food and Drug Administration on closure of inspection of its Ankleshwar plant in Gujarat.
"Glenmark would like to state that its Ankleshwar plant received the EIR (establishment inspection report) yesterday.
The company "announced today the launch of generic paxil CR extended release tablets, 12.5 mg, 25 mg and 37.5 mg, having received an approval from the United States Food and Drug Administration (FDA) earlier", Lupin said in a BSE filing.
Analysts believe that Neuland Labs is a supplier of API (active pharma ingredient) to Teva for this drug, which is used in the therapy of Huntington Disease, a disorder related to tardive dyskinesia. If the new drug application is accepted, Neuland will be a key beneficiary.
According to a notification issued by the US Food and Drug Authority, Dr Reddy's is recalling Olanzapine tablets USP of 2.5 mg while Aurobindo is recalling Pantoprazole Sodium for Injection, 40mg per vial from the market.
During his campaign, US president Donald Trump vowed to ease the burden of the healthcare industry in US by reducing taxes and government regulations. Two important decisions expected from the Trump administration is appointment of Food and Drug Administration (FDA) commissioner and drug price control.
South Korean firm Mezzion Pharma has filed a suit against Dr Reddy's Laboratories in the US alleging that the Indian company hid "significant deficiencies" and misrepresented compliance with the Food and Drug Administration (FDA) cGMP practices.
The US drug regulator has made six observations after the completion of inspection of its Kothur formulation facility in Telangana, Natco said today in a statement.
The US drug regulator gave a tentative nod for the company's Olmesartan Medoxomil tablets, which is used to treat blood pressure.
US FDA gave a clearance to the company's drug Rizatripan Bonzoate tablet, which is used to treat symptoms due to migraine.
The proposed biosimilar trastuzumab is one of the six biologic products co-developed by Mylan and Biocon for the global marketplace, the two companies said in a statement.
Pharmaceutical stocks have been under the US FDA cloud. Will 2017 fare better? CNBC-TV18's Latha Venkatesh & Sonia Shenoy asks Arpit Vyas, MD of Dishman Pharmaceuticals & Chemicals, Surajit Pal of Prabhudas Lilladher and Vishal Manchanda of Nirmal Bang Institutional Equities.
Earlier this month, Sun said it had been informed by the US health regulator of more concerns about its plant in the western Indian state of Gujarat after a recent inspection, but details of the violations were unclear at the time.
Drug firm Zydus Cadila today said the patent litigation relating to Allergan's Delzicol, used to treat ulcerative colitis, has been settled.
Caplin Point Laboratories should be able to foray into the US market by end of 2018, says Chief Promoter and Chairman CC Paarthipan in an interview to CNBC-TV18.
Granules India is looking at expanding its business to new geographies. The company is targeting 30-40 percent bottomline growth in FY18, C Krishna Prasad, MD of company said.
The Maharashtra FDA is checking branded and un-branded lipsticks to check for traces of mercury, which is not permissible in cosmetics. Big companies like Lakme, Revlon and L‘Oreal are under the scanner.
Granules India gets US FDA approval for orange-coloured 200 mg version of ibuprofen. Speaking to CNBC-TV18, C Krishna Prasad said that the market for orange-coloured tablet is around USD 49 million.
Upholding its commitment towards down-gauging and light-weighting, India’s largest multinational flexible packaging materials and solution ...
Medical device experts said they believe it was the first time a manufacturer had issued such a warning to patients about a cyber vulnerability, a hot topic in the industry following revelations last month about possible bugs in pacemakers and defibrillators.
The US Food and Drug Administration (FDA) has given a clean chit to the Chikalthana plant of Wockhardt, reports CNBC Awaaz quoting sources. Official announcement from the FDA is expected in couple of weeks.